CA Stock MarketDetailed Quotes

EVMT Evome Medical Technologies Inc

Watchlist
  • 0.095
  • 0.0000.00%
15min DelayMarket Closed Jun 28 16:00 ET
7.49MMarket Cap-413P/E (TTM)

Evome Medical Technologies Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Feb 28, 2022
(FY)Dec 31, 2021
(Q3)Nov 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
25.71%-612.11K
-11.04%-918.91K
146.78%1.11M
-105.81K
-1.1M
-823.9K
74.76%-827.56K
28.33%-2.37M
-3.28M
-342.38%-423.29K
Net income from continuing operations
-157.77%-4.29M
1.85%-15.6M
-1,276.52%-15.81M
--2.99M
---1.12M
---1.66M
-282.06%-15.9M
67.50%-1.15M
---4.16M
-316.28%-1.5M
Operating gains losses
--571.19K
--25.67K
--0
--2.55K
----
----
----
5.47%-902.87K
---912.6K
93.43%-36
Depreciation and amortization
-47.13%484.59K
108.69%2.48M
-314.90%-772.18K
--1.18M
--1.16M
--916.64K
88.57%1.19M
--359.31K
--631.47K
--298.83K
Asset impairment expenditure
--708.94K
--13.51M
--13.51M
--0
--0
--0
--0
----
--0
----
Remuneration paid in stock
--910
--690.8K
----
----
----
----
--0
----
----
----
Unrealized gains and losses of investment securities
----
----
----
----
----
----
----
99.98%-32
---6.87K
-100.02%-25
Remuneration paid in stock
-170.95%-245.16K
0.75%1.29M
-34.62%286.72K
--264.64K
--391.57K
--345.52K
41.48%1.28M
-58.64%438.57K
--903.95K
322.68%292.49K
Deferred tax
----
----
----
--0
----
----
----
----
--0
----
Other non cashItems
-17.87%246.36K
-117.62%-2.39M
135.21%2.04M
---3.82M
---915.75K
--299.96K
16,166.89%13.59M
---5.8M
--83.52K
--98.61K
Change In working capital
363.67%1.91M
6.35%-924.9K
260.46%1.16M
---726.9K
---635.96K
---723.29K
-753.24%-987.6K
-177.81%-723.68K
--151.18K
549.53%390.54K
-Change in receivables
157.26%653.96K
-25.60%-1.9M
230.12%1.3M
--1.14M
---3.2M
---1.14M
4.42%-1.51M
---1M
---1.58M
---273.84K
-Change in inventory
-131.88%-437.19K
360.62%4.65M
974.64%1.4M
--1.22M
--655.43K
--1.37M
-1,104.74%-1.78M
---160.43K
--177.44K
---219.84K
-Change in prepaid assets
-717.46%-192.95K
-2,900.07%-1.1M
284.31%383.35K
---145.11K
---1.36M
--31.25K
-109.39%-36.51K
-390.39%-208K
--388.68K
1,488.80%490.89K
-Change in payables and accrued expense
31.05%-353.8K
-151.76%-972.45K
-593.74%-3.18M
---179.39K
--2.9M
---513.09K
172.45%1.88M
-59.43%643.64K
--689.61K
903.28%293.25K
-Change in other current liabilities
575.14%2.24M
-443.17%-1.6M
95,849.39%1.25M
---2.75M
--371.83K
---470.83K
-2.65%466.83K
--1.3K
--479.55K
--100.07K
Cash from discontinued investing activities
Operating cash flow
25.71%-612.11K
-11.04%-918.91K
146.78%1.11M
---105.81K
---1.1M
---823.9K
75.00%-827.56K
28.33%-2.37M
---3.31M
-342.38%-423.29K
Investing cash flow
Cash flow from continuing investing activities
58.78%-38.43K
72.86%-1.52M
105.04%23.96K
-91.52K
-1.36M
-93.23K
-21.48%-5.6M
89.89%-475.27K
-4.61M
-5,434.11%-5.08M
Net PPE purchase and sale
58.78%-38.43K
68.21%-203.27K
268.64%23.96K
---91.52K
---42.48K
---93.23K
-1,313.29%-639.47K
---14.21K
---45.25K
---21.14K
Net intangibles purchas and sale
----
--0
--0
--0
----
----
---243.2K
----
--0
--0
Net business purchase and sale
----
72.09%-1.32M
--0
--0
---1.32M
--0
6.81%-4.71M
---245.75K
---5.06M
---5.27M
Net investment purchase and sale
----
----
----
----
----
----
----
--0
--496.53K
--0
Cash from discontinued investing activities
Investing cash flow
58.78%-38.43K
72.86%-1.52M
105.04%23.96K
---91.52K
---1.36M
---93.23K
-21.48%-5.6M
89.89%-475.27K
---4.61M
-5,434.11%-5.08M
Financing cash flow
Cash flow from continuing financing activities
-109.89%-255.03K
112.46%824.54K
-130.69%-1.54M
19.67K
-229.88K
2.58M
158.92%388.09K
27.93%5.03M
-658.7K
-200.33K
Net issuance payments of debt
-110.03%-255.03K
196.52%790.64K
-218.64%-1.54M
--19.67K
---229.88K
--2.54M
-118.13%-819.14K
--1.3M
---375.54K
---200.33K
Net common stock issuance
----
----
----
--0
--0
--0
----
----
--0
----
Proceeds from stock option exercised by employees
--0
-84.68%33.9K
--0
--0
--0
--33.9K
-41.29%221.28K
-100.00%-1
--376.89K
--1
Net other financing activities
----
----
----
----
----
----
249.37%985.95K
---535.17K
---660.05K
--0
Cash from discontinued financing activities
Financing cash flow
-109.89%-255.03K
112.46%824.54K
-130.69%-1.54M
--19.67K
---229.88K
--2.58M
158.92%388.09K
27.93%5.03M
---658.7K
---200.33K
Net cash flow
Beginning cash position
-52.36%918.68K
-76.07%1.93M
-82.82%1.05M
--1.4M
--3.7M
--1.93M
-35.57%8.06M
-20.98%6.13M
--12.51M
46.75%11.68M
Current changes in cash
-154.54%-905.57K
73.28%-1.61M
-118.82%-411.13K
---177.66K
---2.68M
--1.66M
29.61%-6.04M
153.62%2.18M
---8.58M
-3,031.61%-5.7M
Effect of exchange rate changes
103.16%219.06K
755.48%603.43K
208.81%277.16K
---167.8K
--386.26K
--107.82K
-117.16%-92.06K
-216.39%-254.73K
--536.36K
900.64%155.88K
End cash Position
-93.72%232.17K
-52.36%918.68K
-88.60%918.68K
--1.05M
--1.4M
--3.7M
-56.82%1.93M
0.00%8.06M
--4.47M
-20.98%6.13M
Free cash from
29.07%-650.54K
34.38%-1.12M
147.51%1.13M
---197.33K
---1.14M
---917.14K
49.03%-1.71M
29.08%-2.38M
---3.36M
-364.47%-444.43K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Feb 28, 2022(FY)Dec 31, 2021(Q3)Nov 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 25.71%-612.11K-11.04%-918.91K146.78%1.11M-105.81K-1.1M-823.9K74.76%-827.56K28.33%-2.37M-3.28M-342.38%-423.29K
Net income from continuing operations -157.77%-4.29M1.85%-15.6M-1,276.52%-15.81M--2.99M---1.12M---1.66M-282.06%-15.9M67.50%-1.15M---4.16M-316.28%-1.5M
Operating gains losses --571.19K--25.67K--0--2.55K------------5.47%-902.87K---912.6K93.43%-36
Depreciation and amortization -47.13%484.59K108.69%2.48M-314.90%-772.18K--1.18M--1.16M--916.64K88.57%1.19M--359.31K--631.47K--298.83K
Asset impairment expenditure --708.94K--13.51M--13.51M--0--0--0--0------0----
Remuneration paid in stock --910--690.8K------------------0------------
Unrealized gains and losses of investment securities ----------------------------99.98%-32---6.87K-100.02%-25
Remuneration paid in stock -170.95%-245.16K0.75%1.29M-34.62%286.72K--264.64K--391.57K--345.52K41.48%1.28M-58.64%438.57K--903.95K322.68%292.49K
Deferred tax --------------0------------------0----
Other non cashItems -17.87%246.36K-117.62%-2.39M135.21%2.04M---3.82M---915.75K--299.96K16,166.89%13.59M---5.8M--83.52K--98.61K
Change In working capital 363.67%1.91M6.35%-924.9K260.46%1.16M---726.9K---635.96K---723.29K-753.24%-987.6K-177.81%-723.68K--151.18K549.53%390.54K
-Change in receivables 157.26%653.96K-25.60%-1.9M230.12%1.3M--1.14M---3.2M---1.14M4.42%-1.51M---1M---1.58M---273.84K
-Change in inventory -131.88%-437.19K360.62%4.65M974.64%1.4M--1.22M--655.43K--1.37M-1,104.74%-1.78M---160.43K--177.44K---219.84K
-Change in prepaid assets -717.46%-192.95K-2,900.07%-1.1M284.31%383.35K---145.11K---1.36M--31.25K-109.39%-36.51K-390.39%-208K--388.68K1,488.80%490.89K
-Change in payables and accrued expense 31.05%-353.8K-151.76%-972.45K-593.74%-3.18M---179.39K--2.9M---513.09K172.45%1.88M-59.43%643.64K--689.61K903.28%293.25K
-Change in other current liabilities 575.14%2.24M-443.17%-1.6M95,849.39%1.25M---2.75M--371.83K---470.83K-2.65%466.83K--1.3K--479.55K--100.07K
Cash from discontinued investing activities
Operating cash flow 25.71%-612.11K-11.04%-918.91K146.78%1.11M---105.81K---1.1M---823.9K75.00%-827.56K28.33%-2.37M---3.31M-342.38%-423.29K
Investing cash flow
Cash flow from continuing investing activities 58.78%-38.43K72.86%-1.52M105.04%23.96K-91.52K-1.36M-93.23K-21.48%-5.6M89.89%-475.27K-4.61M-5,434.11%-5.08M
Net PPE purchase and sale 58.78%-38.43K68.21%-203.27K268.64%23.96K---91.52K---42.48K---93.23K-1,313.29%-639.47K---14.21K---45.25K---21.14K
Net intangibles purchas and sale ------0--0--0-----------243.2K------0--0
Net business purchase and sale ----72.09%-1.32M--0--0---1.32M--06.81%-4.71M---245.75K---5.06M---5.27M
Net investment purchase and sale ------------------------------0--496.53K--0
Cash from discontinued investing activities
Investing cash flow 58.78%-38.43K72.86%-1.52M105.04%23.96K---91.52K---1.36M---93.23K-21.48%-5.6M89.89%-475.27K---4.61M-5,434.11%-5.08M
Financing cash flow
Cash flow from continuing financing activities -109.89%-255.03K112.46%824.54K-130.69%-1.54M19.67K-229.88K2.58M158.92%388.09K27.93%5.03M-658.7K-200.33K
Net issuance payments of debt -110.03%-255.03K196.52%790.64K-218.64%-1.54M--19.67K---229.88K--2.54M-118.13%-819.14K--1.3M---375.54K---200.33K
Net common stock issuance --------------0--0--0----------0----
Proceeds from stock option exercised by employees --0-84.68%33.9K--0--0--0--33.9K-41.29%221.28K-100.00%-1--376.89K--1
Net other financing activities ------------------------249.37%985.95K---535.17K---660.05K--0
Cash from discontinued financing activities
Financing cash flow -109.89%-255.03K112.46%824.54K-130.69%-1.54M--19.67K---229.88K--2.58M158.92%388.09K27.93%5.03M---658.7K---200.33K
Net cash flow
Beginning cash position -52.36%918.68K-76.07%1.93M-82.82%1.05M--1.4M--3.7M--1.93M-35.57%8.06M-20.98%6.13M--12.51M46.75%11.68M
Current changes in cash -154.54%-905.57K73.28%-1.61M-118.82%-411.13K---177.66K---2.68M--1.66M29.61%-6.04M153.62%2.18M---8.58M-3,031.61%-5.7M
Effect of exchange rate changes 103.16%219.06K755.48%603.43K208.81%277.16K---167.8K--386.26K--107.82K-117.16%-92.06K-216.39%-254.73K--536.36K900.64%155.88K
End cash Position -93.72%232.17K-52.36%918.68K-88.60%918.68K--1.05M--1.4M--3.7M-56.82%1.93M0.00%8.06M--4.47M-20.98%6.13M
Free cash from 29.07%-650.54K34.38%-1.12M147.51%1.13M---197.33K---1.14M---917.14K49.03%-1.71M29.08%-2.38M---3.36M-364.47%-444.43K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg